Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished May 23, 2026 6:31 AM ・ Updated Jun 13, 2026 11:53 PM ・ 2 min read ・ Source: PR Times
KangPei (6919) announced that the shareholders' meeting on May 22, 2026, approved the lifting of non-compete restrictions for Independent Director Luo Bao-Zhu, who serves on other biotech boards.
On May 22, 2026, KangPei Biotech Co., Ltd. held a shareholders' meeting and approved the resolution to lift the non-compete restrictions for Independent Director Luo Bao-Zhu. Luo currently serves as an independent director at both Everfront Biotech Inc. and PharmaEngine, Inc. The resolution was passed in accordance with Article 209 of the Company Act.
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.